2016 Clinical Laboratory Fee Schedule: Why Quantitative Drug Testing Should Not be Reduced to a Single Code
July 6, 2015
Misters Yussuf Abdelaleem and Jacob Slowik, partners at Joseph, Aleem and Slowik who represent a number of preeminent clinical laboratories and medical practices in the southeastern US, contacted me recently with their concerns about CMS’ proposal to use a single CPT code to reimburse clinical laboratories for confirmatory drug testing beginning in 2016. Read more →